We are developing the world’s most advanced platform to discover novel microbiome-based therapeutics for dermatologic indications. Our platform is enabled by terabytes of DNA sequencing data derived from human skin samples across healthy individuals and patients with targeted skin diseases and a cutting-edge technology platform to successfully identify the functions added and lost to the microbiome by organisms; we seek to extract unique insights and understand the implications for skin health.
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…